Search

Mexico approves emergency use of Pfizer’s COVID-19 pills

News, World | | | By Reuters Reuters

Listen to this article:

FILE PHOTO: Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS

MEXICO CITY (Reuters) – Mexican health regulator COFEPRIS said on Friday it had approved U.S. pharmaceutical company Pfizer’s antiviral oral treatment against COVID-19 for emergency use in adults with light or moderate risk of complications.

Paxlovid, which combines nirmatrelvir and ritonavir in a tablet, will require a prescription, it said in a statement.

The treatment was nearly 90% effective in preventing hospitalizations and deaths, and data suggested it retains its effectiveness against the Omicron variant, Pfizer has said.

Late last year, COFEPRIS had approved a similar treatment by Eli Lilly and Co.

Array
(
    [post_type] => post
    [post_status] => publish
    [orderby] => date
    [order] => DESC
    [update_post_term_cache] => 
    [update_post_meta_cache] => 
    [cache_results] => 
    [category__in] => 1
    [posts_per_page] => 4
    [offset] => 0
    [no_found_rows] => 1
    [date_query] => Array
        (
            [0] => Array
                (
                    [after] => Array
                        (
                            [year] => 2024
                            [month] => 01
                            [day] => 19
                        )

                    [inclusive] => 1
                )

        )

)

No Posts found for specific category